Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plan B Label Comprehension, Actual Use Studies Completed

This article was originally published in The Tan Sheet

Executive Summary

More than 93% of women understood the Plan B emergency contraceptive is to prevent pregnancy after unprotected sex, does not prevent transmission of HIV/AIDS and should not be used by women who are already pregnant, according to a label comprehension study published in the August Obstetrics & Gynecology

You may also be interested in...



WCC Plan B OTC Marketing Partnership Sought Pending Switch Approval

Women's Capital Corporation "is in discussions with a number of potential strategic marketers" to sell an OTC version of its Plan B emergency contraceptive pending approval of the firm's April 21 switch application

WCC Plan B OTC Marketing Partnership Sought Pending Switch Approval

Women's Capital Corporation "is in discussions with a number of potential strategic marketers" to sell an OTC version of its Plan B emergency contraceptive pending approval of the firm's April 21 switch application

WCC Plan B OTC Marketing Partnership Sought Pending Switch Approval

Women's Capital Corporation "is in discussions with a number of potential strategic marketers" to sell an OTC version of its Plan B emergency contraceptive pending approval of the firm's April 21 switch application

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094459

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel